Bio-Rad Laboratories, Inc. BIO.B Other Income (Expense)
Other Income (Expense) at other companies
Other financials
Where this comes from
Reported directly by Bio-Rad Laboratories, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.
The official record: Bio-Rad Laboratories, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bio-Rad Laboratories, Inc.'s other income (expense).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Bio-Rad Laboratories, Inc.'s other income (expense)?
- Bio-Rad Laboratories, Inc. (BIO.B) reported other income (expense) of $24.2M in Q1 2026.
- How has Bio-Rad Laboratories, Inc.'s other income (expense) changed year-over-year?
- Bio-Rad Laboratories, Inc.'s other income (expense) decreased by 34.9% year-over-year, from $37.2M to $24.2M.
- What is the long-term trend for Bio-Rad Laboratories, Inc.'s other income (expense)?
- Over 4 years (2021 to 2025), Bio-Rad Laboratories, Inc.'s other income (expense) has grown at a 35.5% compound annual growth rate (CAGR), from $26.78M to $90.3M.
- What does other income (expense) mean?
- Other income and expense, net, includes all non-operating items that do not fit into core categories like interest or taxes. This can include foreign exchange gains or losses, asset disposals, or one-time legal settlements. It provides a catch-all view of peripheral financial impacts on the bottom line.